$SNPS

Why is Synopsys stock rallying today?

Synopsys (SNPS) stock rose 3.0% ahead of its Q3 2026 earnings release on August 26. Rosenblatt Securities reiterated a Buy rating with a $575 price target, projecting $2.435B revenue, up 40% YoY. The company has beaten estimates in the past two quarters and has a $11B backlog. The broader market also supported gains, with the Nasdaq and S&P 500 advancing.

Original reporting
Published Aug 25, 2026, 6:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 7:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The Rosenblatt note adds fresh, bullish guidance that may attract momentum traders ahead of the earnings release.

02

Market read

A 3% intraday rally driven by analyst optimism signals short‑term buying interest and sets a higher price floor before earnings.

03

What to watch

Potential supply‑chain constraints for silicon wafers could limit growth despite AI tailwinds.

Relevance 8/10Novelty 7/10Timing: today

Background

Synopsys is a leading electronic design automation (EDA) provider; its upcoming Q3 earnings are closely watched.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys stock rose 3% in afternoon trading after Rosenblatt Securities issued a bullish pre‑earnings note with a $575 price target and a $2.435 B Q3 revenue forecast.

Expected impact

Expect continued upside toward $560‑$575 range before earnings release.

Evidence & confidence

The combination of a high price target, strong growth guidance, and a low 52‑week price level creates a compelling catalyst for traders.

Market effects

Positive sentiment may spill over to other EDA firms, pressuring peers like Cadence to underperform.

U.S. tech sector gains, modest lift for Nasdaq‑listed semiconductor names.

Boosts global AI‑related hardware design spend outlook.

Counterpoint

If earnings miss the lofty guidance, the rally could reverse sharply.

Key entities

  • Synopsys

    EDA software vendor

  • Rosenblatt Securities

    Equity research house issuing the note

Related articles

$SNPSHighAI 9/10

Synopsys Could Be Set Up To Surprise Investors On August 26th

Synopsys (SNPS) is expected to report fiscal Q3 earnings on August 26, 2026. The company has shown two consecutive quarters of beating earnings estimates and raising guidance, with revenue up 41.98% year-over-year. Management has guided for continued growth in Q3. The company's expanding margins and debt reduction are noted as positive factors. Analysts are generally bullish, with an average price target of $561.03. Cadence Design Systems (CDNS) is mentioned as a comparable, but with slower grow

$SNPSHighAI 9/10

Dear Synopsys Stock Fans, Mark Your Calendars for August 26

Synopsys (SNPS) reported Q2 FY2026 revenue of $2.3B, up 41.9% YOY, beating estimates. Adjusted EPS was $3.35, down 8.7% YOY but above forecasts. Non-GAAP net income rose 12.4% YOY. The company raised full-year guidance, targeting $9.665B in revenue and $14.72-$14.80 in non-GAAP EPS. Analysts rate SNPS 'Strong Buy' with an average price target of $560, implying 35.5% upside.

$SNPSMedAI 8/10

Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary.

Synopsys raised its full-year fiscal 2026 revenue guidance midpoint to $9.665 billion and lifted non-GAAP EPS guidance to $14.76 at the midpoint, driven by strong first-half performance, accelerating Ansys integration synergies, and expanded operating margins. For Q3 fiscal 2026, management guided revenue of $2.41–$2.46 billion and non-GAAP EPS of $3.63–$3.69.

$SNPSMed

Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed

Synopsys' valuation remains difficult to assess on its headline numbers. The forward GAAP price-to-earnings (P/E) makes it look extraordinarily expensive, while the price-to-sales (P/S) ratio does the opposite. The reason is the $35 billion Ansys acquisition. The forward P/E of 138.39x sits 91% above its 5-year average of 72.47x. The Ansys acquisition is holding down the reported earnings, making the stock look inflated.

$SNPSMed

Synopsys Doubles Down on AI Chip Design With Microsoft and AMD. How to Play SNPS Stock Here.

Synopsys (SNPS) shares rose more than 4% after the company unveiled autonomous AI workflows for chip design at the 2026 DAC Chips to Systems Conference. Synopsys said the workflows, built with Microsoft (MSFT) and evaluated by AMD (AMD), can cut debug cycles by 25% to 40%. SNPS reported fiscal Q2 2026 revenue of $2.27B and raised FY2026 outlook to about $9.665B revenue and $14.76 EPS.